O. Zenker

725 total citations
16 papers, 527 citations indexed

About

O. Zenker is a scholar working on Immunology, Hematology and Epidemiology. According to data from OpenAlex, O. Zenker has authored 16 papers receiving a total of 527 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 10 papers in Hematology and 5 papers in Epidemiology. Recurrent topics in O. Zenker's work include Immunodeficiency and Autoimmune Disorders (11 papers), Platelet Disorders and Treatments (8 papers) and Blood groups and transfusion (6 papers). O. Zenker is often cited by papers focused on Immunodeficiency and Autoimmune Disorders (11 papers), Platelet Disorders and Treatments (8 papers) and Blood groups and transfusion (6 papers). O. Zenker collaborates with scholars based in Germany, United States and Switzerland. O. Zenker's co-authors include Mikhail Rojavin, Peter Kießling, Melvin Berger, Isaac Melamed, Sheldon Spector, Mary Beth Fasano, Jordan S. Orange, Michael Borte, John B. Hagan and Stephen Jolles and has published in prestigious journals such as Blood, Journal of Allergy and Clinical Immunology and British Journal of Dermatology.

In The Last Decade

O. Zenker

16 papers receiving 505 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
O. Zenker Germany 9 345 271 149 90 89 16 527
V Brennan United Kingdom 10 319 0.9× 175 0.6× 88 0.6× 32 0.4× 161 1.8× 17 409
Hans Hägglund Sweden 14 419 1.2× 119 0.4× 88 0.6× 48 0.5× 106 1.2× 29 716
G Stark United Kingdom 8 113 0.3× 80 0.3× 60 0.4× 70 0.8× 48 0.5× 12 471
Andrea Váncsa Hungary 12 139 0.4× 40 0.1× 44 0.3× 49 0.5× 48 0.5× 29 566
C Gaud France 11 170 0.5× 85 0.3× 46 0.3× 334 3.7× 29 0.3× 16 555
Claudia Orelio Netherlands 14 146 0.4× 119 0.4× 74 0.5× 43 0.5× 41 0.5× 19 495
Christoph Scheid Germany 12 65 0.2× 359 1.3× 38 0.3× 29 0.3× 94 1.1× 37 573
T. Radaszkiewicz Austria 10 87 0.3× 94 0.3× 29 0.2× 75 0.8× 133 1.5× 27 409
Amy Morgan United States 5 200 0.6× 91 0.3× 16 0.1× 31 0.3× 56 0.6× 6 667
J P Farcet France 10 139 0.4× 32 0.1× 19 0.1× 100 1.1× 53 0.6× 17 382

Countries citing papers authored by O. Zenker

Since Specialization
Citations

This map shows the geographic impact of O. Zenker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by O. Zenker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites O. Zenker more than expected).

Fields of papers citing papers by O. Zenker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by O. Zenker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by O. Zenker. The network helps show where O. Zenker may publish in the future.

Co-authorship network of co-authors of O. Zenker

This figure shows the co-authorship network connecting the top 25 collaborators of O. Zenker. A scholar is included among the top collaborators of O. Zenker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with O. Zenker. O. Zenker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
2.
Kanni, Theodora, et al.. (2018). Complement activation in hidradenitis suppurativa: a new pathway of pathogenesis?. British Journal of Dermatology. 179(2). 413–419. 60 indexed citations
3.
Léger, Jean‐Marc, Jan De Bleecker, Claudia Sommer, et al.. (2013). Efficacy and safety of Privigen® in patients with chronic inflammatory demyelinating polyneuropathy: results of a prospective, single‐arm, open‐label Phase III study (the PRIMA study). Journal of the Peripheral Nervous System. 18(2). 130–140. 59 indexed citations
4.
Bexon, Martin, Jeffrey S. Baggish, Mikhail Rojavin, M. S. Berger, & O. Zenker. (2012). Increased Frequency of Infections at the End of the IVIG Dosing Cycle: Effect Characterization from Three Phase III Studies. Journal of Allergy and Clinical Immunology. 129(2). AB193–AB193. 4 indexed citations
5.
Zenker, O., Mikhail Rojavin, Jeffrey S. Baggish, & Martin Bexon. (2012). Evaluation of the Relationship between Injection Site Reaction Rate and SCIG Doses in Patients with Primary Immunodeficiencies. Journal of Allergy and Clinical Immunology. 129(2). AB194–AB194. 1 indexed citations
6.
Berger, Melvin, Mikhail Rojavin, Peter Kießling, & O. Zenker. (2011). Pharmacokinetics of subcutaneous immunoglobulin and their use in dosing of replacement therapy in patients with primary immunodeficiencies. Clinical Immunology. 139(2). 133–141. 80 indexed citations
7.
Borte, Michael, Małgorzata Pac, M. Şerban, et al.. (2011). Efficacy and Safety of Hizentra®, a New 20% Immunoglobulin Preparation for Subcutaneous Administration, in Pediatric Patients with Primary Immunodeficiency. Journal of Clinical Immunology. 31(5). 752–61. 42 indexed citations
8.
Jolles, Stephen, Ewa Bernatowska, Javier de Gracia, et al.. (2011). Efficacy and safety of Hizentra® in patients with primary immunodeficiency after a dose-equivalent switch from intravenous or subcutaneous replacement therapy. Clinical Immunology. 141(1). 90–102. 96 indexed citations
9.
Hagan, John B., Mary Beth Fasano, Sheldon Spector, et al.. (2010). Efficacy and Safety of a New 20% Immunoglobulin Preparation for Subcutaneous Administration, IgPro20, in Patients With Primary Immunodeficiency. Journal of Clinical Immunology. 30(5). 734–745. 108 indexed citations
10.
Jolles, Stephen, et al.. (2010). Trough Levels of 20% Subcutaneous Immunoglobulin (SCIG) When Switching from SCIg. Journal of Allergy and Clinical Immunology. 125(2). AB142–AB142. 2 indexed citations
11.
Jolles, Stephen, Victor Cristea, V. Wahn, et al.. (2010). Efficacy and Safety of IgPro20, a 20% Immunoglobulin for Subcutaneous Administration, in Patients with Primary Immunodeficiency Switching from Intravenous Replacement Therapy. Clinical Immunology. 135. S86–S87. 2 indexed citations
12.
Hagan, J.J., Sheldon Spector, Richard L. Wasserman, et al.. (2010). Efficacy and Safety of a New 20% Immunoglobulin Preparation for Subcutaneous Administration, IgPro20, in Patients with Primary Immunodeficiency. Journal of Allergy and Clinical Immunology. 125(2). AB140–AB140. 2 indexed citations
13.
14.
Berger, Melvin, Charlotte Cunningham‐Rundles, Francisco A. Bonilla, et al.. (2007). Carimune NF Liquid is a Safe and Effective Immunoglobulin Replacement Therapy in Patients with Primary Immunodeficiency Diseases. Journal of Clinical Immunology. 27(5). 503–509. 19 indexed citations
15.
Robak, Tadeusz, et al.. (2007). Efficacy and Safety of a New Intravenous Immunoglobulin Product in Patients with Chronic Immune Thrombocytopenic Purpura.. Blood. 110(11). 1307–1307. 2 indexed citations
16.
Aledort, Louis M., A. Salama, Л. В. Ковалева, et al.. (2007). Efficacy and safety of intravenous anti-D immunoglobulin (Rhophylac®) in chronic immune thrombocytopenic purpura. Hematology. 12(4). 289–295. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by V Brennan Breakdown of academic impact, for papers by Hans Hägglund Breakdown of academic impact, for papers by G Stark Breakdown of academic impact, for papers by Andrea Váncsa Breakdown of academic impact, for papers by C Gaud Breakdown of academic impact, for papers by Claudia Orelio Breakdown of academic impact, for papers by Christoph Scheid Breakdown of academic impact, for papers by T. Radaszkiewicz Breakdown of academic impact, for papers by Amy Morgan Breakdown of academic impact, for papers by J P Farcet
Rankless by CCL
2026